Acutus Medical to Cancel Third Quarter 2023 Conference Call

Rhea-AI Summary

Acutus Medical, Inc. (Nasdaq: AFIB) Cancels Q3 Results Conference Call and Webcast After Strategic Realignment and Corporate Restructuring

Positive

• None.

Negative

• Cancellation of Q3 results conference call and webcast may lead to reduced transparency and investor communication.

CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company’s announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023.

About Acutus Medical, Inc.
Acutus is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. Founded in 2011, Acutus is based in Carlsbad, California.

Investor Contact:

Chad Hollister

Acutus Medical, Inc.

D: 442-232-6080

investors@acutus.com

FAQ

Why did Acutus Medical, Inc. cancel its Q3 results conference call and webcast?

Acutus canceled the call and webcast following a strategic realignment and corporate restructuring, along with the release of its Q3 results on November 8, 2023.

What is the ticker symbol of Acutus Medical, Inc.?

The ticker symbol for Acutus Medical, Inc. is AFIB.

When was the Q3 results conference call and webcast scheduled to take place?

The call and webcast were previously scheduled for Monday, November 13, 2023.